Incidence, predictors and clinical impact of upper gastrointestinal bleeding after transcatheter aortic valve replacement

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Moderate or Severe Mitral and Tricuspid Valves Regurgitation after Transcatheter Aortic Valve Replacement

Am Heart J

Abraham B, Suppah M, Farina J, Botros M, Fath A, Kaldas S, Megaly M, Chao CJ, Arsanjani R, Ayoub C, Fortuin FD, Sweeney J, Pellikka P, Nkomo V, Alkhouli M, Holmes D Jr, Badr A, Alsidawi S

doi: 10.1016/j.ahj.2024.11.003

Heart, Artery and Coronary DiseasesTherapy and Intervention

Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves

JACC Cardiovasc Interv

Zahr F, Elmariah S, Vemulapalli S, Kodali SK, Hahn RT, Anderson AS, Eleid MF, Davidson CJ, Sharma RP, O'Neill WW, Bethea B, Thourani VH, Chakravarty T, Gupta A, Makkar RR

doi: 10.1016/j.jcin.2024.07.005

Heart, Artery and Coronary DiseasesFurther Publications

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Clin Res Cardiol

Saad M, Seoudy H, Bramlage K, Bramlage P, Voran JC, Puehler T, Lutter G, Allali A, Landt M, Frank J, Bisht O, Salem M, Wienemann H, Adam M, Zeus T, Veulemans V, Bleiziffer S, Rudolph TK, Frank D

doi: 10.1007/s00392-025-02611-w

Heart, Artery and Coronary DiseasesTherapy and Intervention

Predicted prosthesis-patient mismatch and long-term clinical outcomes after transcatheter aortic valve replacement: a SWEDEHEART study

Am Heart J

Ellfors E, Dismorr M, Rück A, Settergren M, Sartipy U, Glaser N

doi: 10.1016/j.ahj.2024.07.009

Heart, Artery and Coronary DiseasesTherapy and Intervention

The impact of elevated C-reactive protein levels on long-term outcomes of patients undergoing transcatheter aortic valve replacement

Cardiovasc Revasc Med

Brunner S, Moccetti F, Loretz L, Conrad N, Bossard M, Attinger-Toller A, Kurmann R, Cuculi F, Wolfrum M, Toggweiler S

doi: 10.1016/j.carrev.2024.07.002

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial

JAMA Cardiol

Tchétché D, Mehran R, Blackman DJ, Khalil RF, Möllmann H, Abdel-Wahab M, Ben Ali W, Mahoney PD, Ruge H, Bleiziffer S, Lin L, Szerlip M, Grubb KJ, Byku I, Guerrero M, Gillam LD, Petronio AS, Attizzani GF, Batchelor WB, Gada H, Rogers T, Rovin JD, Whisenant B, Benton S, Gardner B, Padang R, Althouse AD, Herrmann HC

doi: 10.1001/jamacardio.2024.3241

Heart, Artery and Coronary DiseasesTherapy and Intervention

Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries

J Am Coll Cardiol

Durand E, Eltchaninoff H, Tchetche D, Levesque T, Garmendia C, Iung B, Benamer H, Cayla G, Van Belle E, Commeau P, Le Breton H, Cuisset T, Akodad M, Verhoye JP, Beurtheret S, du Chayla F, Leclere M, Gilard M, Dumonteil N, STOP-AS and France TAVI Investigators

doi: 10.1016/j.jacc.2024.11.048

Heart, Artery and Coronary DiseasesTherapy and Intervention

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

J Am Coll Cardiol

Forrest JK, Yakubov SJ, Deeb GM, Gada H, Mumtaz MA, Ramlawi B, Bajwa T, Crouch J, Merhi W, Wai Sang SL, Kleiman NS, Petrossian G, Robinson NB, Sorajja P, Iskander A, Berthoumieu P, Tchétché D, Feindel C, Horlick EM, Saito S, Oh JK, Jung Y, Reardon MJ, Low Risk Trial Investigators

doi: 10.1016/j.jacc.2025.03.004

Heart, Artery and Coronary DiseasesTherapy and Intervention

Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Aortic Stenosis and Cardiogenic Shock

Eur Heart J Acute Cardiovasc Care

Ismayl M, Ahmed H, Goldsweig AM, Eleid MF, Guerrero M, Rihal CS

doi: 10.1093/ehjacc/zuae103

Related content

Impact of Moderate or Severe Mitral and Tricuspid Valves Regurgitation after Transcatheter Aortic Valve Replacement

Impact of Tricuspid Regurgitation on Outcomes of Transcatheter Aortic Valve Replacement With Balloon-Expandable Valves

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison

Predicted prosthesis-patient mismatch and long-term clinical outcomes after transcatheter aortic valve replacement: a SWEDEHEART study

The impact of elevated C-reactive protein levels on long-term outcomes of patients undergoing transcatheter aortic valve replacement

Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial

Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries

5-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis

Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Aortic Stenosis and Cardiogenic Shock